The new WHO global strategic initiative encouraged countries to adopt digital health tools to support universal health coverage.

In patients with plaque psoriasis, family history and palmoplantar involvement were among the predictors of early super response to bimekizumab.

Black and Hispanic patients with MCC are more likely to have tumors on UV-protected sites, which is associated with better outcomes.

Concomitant IBD reduces disease control and treatment response among patients with PsA receiving biologic therapy.

Ixekizumab was more effective for the treatment of mild to moderate psoriasis vs severe psoriasis at most time points through 52 weeks.

Officials stressed that the public health risk remains low after the first confirmed case of H5N5 in a human. HealthDay News — A Washington state resident has become the first person in the United ...

Patients with prescriptions can buy the 0.25 mg and 0.5 mg injections of Ozempic and Wegovy for $199 per month for 2 months, then the monthly cost will rise to $349. HealthDay News — People paying out ...

At 48 weeks of baricitinib, most patients (63.2%) achieved significant improvement in the severity of alopecia areata, with decreases seen among various trichoscopic signs from baseline. A real-world ...

Time-to-event analyses showed no significant differences in the likelihood of developing ocular manifestations of HLA-B27-associated diseases between TNF, JAK, and IL inhibitors. Tumor necrosis factor ...

Results of the cross-sectional study showed that impaired lung function was associated with an increased risk for spondyloarthritis. Impaired lung function — particularly preserved ratio impaired ...

FDA officials say the existing black box warnings were based on outdated 2002 study data involving older patients and old drug formulas. HealthDay News — The U.S. Food and Drug Administration (FDA) is ...

As of November 11, 2025, 15 infants across 12 states had been hospitalized with botulism after consuming ByHeart baby formula. HealthDay News — ByHeart Inc. has announced a full recall of all its ...